It has multiple actions including: potentiation of glucose-mediated insulin secretion mechanisms identified: increased -cell proliferation, resulting in an increase -cell mass (Fusco et al, 2017) stimulation of insulin biosynthesis at the translational level, helping to maintain -cell insulin stores and secretory capacity (Baggio & Drucker, 2007) because the GLP-1 effect is glucose-dependent (there is more insulin release when glucose levels are elevated, but less effect when glucose levels are normal), GLP-1 agonists have a lower risk for producing hypoglycemia compared to sulfonylureas (that chronically stimulate insulin release, independent of glucose concentration) suppression of postprandial glucagon release Evidence indicates that stimulation of pancreatic cells by GLP-1 increases their glucose sensitivity, resulting in less glucagon release at any glucose level (Baggio & Drucker, 2007)
While zinc and semaglutide can potentially work together to support metabolic health, combining them without medical guidance can pose risks
Regular physician check-ins and tracking doses can improve adherence and minimize the consequences of missed doses
Review 5 indirect causes, uric acid risks, and 8 relief tactics
For instance, too much potassium can cause hyperkalaemia, particularly in patients with kidney disease
